B. Akdogan Et Al. , "IS INTERMITTENT DOCETAXEL CHEMOTHERAPY REASONABLE IN HORMONE REFRACTORY PROSTATE CANCER? A PILOT RANDOMIZED STUDY," 104th Annual Meeting of the American-Urological-Association , vol.181, Illinois, United States Of America, pp.233, 2009
Akdogan, B. Et Al. 2009. IS INTERMITTENT DOCETAXEL CHEMOTHERAPY REASONABLE IN HORMONE REFRACTORY PROSTATE CANCER? A PILOT RANDOMIZED STUDY. 104th Annual Meeting of the American-Urological-Association , (Illinois, United States Of America), 233.
Akdogan, B., Yazici, S., Kirdal, Y., Inci, K., Erman, M., & Ozen, H., (2009). IS INTERMITTENT DOCETAXEL CHEMOTHERAPY REASONABLE IN HORMONE REFRACTORY PROSTATE CANCER? A PILOT RANDOMIZED STUDY . 104th Annual Meeting of the American-Urological-Association (pp.233). Illinois, United States Of America
Akdogan, Bulent Et Al. "IS INTERMITTENT DOCETAXEL CHEMOTHERAPY REASONABLE IN HORMONE REFRACTORY PROSTATE CANCER? A PILOT RANDOMIZED STUDY," 104th Annual Meeting of the American-Urological-Association, Illinois, United States Of America, 2009
Akdogan, Bulent Et Al. "IS INTERMITTENT DOCETAXEL CHEMOTHERAPY REASONABLE IN HORMONE REFRACTORY PROSTATE CANCER? A PILOT RANDOMIZED STUDY." 104th Annual Meeting of the American-Urological-Association , Illinois, United States Of America, pp.233, 2009
Akdogan, B. Et Al. (2009) . "IS INTERMITTENT DOCETAXEL CHEMOTHERAPY REASONABLE IN HORMONE REFRACTORY PROSTATE CANCER? A PILOT RANDOMIZED STUDY." 104th Annual Meeting of the American-Urological-Association , Illinois, United States Of America, p.233.
@conferencepaper{conferencepaper, author={Bulent Akdogan Et Al. }, title={IS INTERMITTENT DOCETAXEL CHEMOTHERAPY REASONABLE IN HORMONE REFRACTORY PROSTATE CANCER? A PILOT RANDOMIZED STUDY}, congress name={104th Annual Meeting of the American-Urological-Association}, city={Illinois}, country={United States Of America}, year={2009}, pages={233} }